{"id":"NCT00917384","sponsor":"Eli Lilly and Company","briefTitle":"Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma","officialTitle":"A Phase 3, Randomized, Double-Blinded Study of IMC-1121B and Best Supportive Care (BSC) Versus Placebo and BSC in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First-Line Platinum- or Fluoropyrimidine-Containing Combination Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-08","primaryCompletion":"2012-07","completion":"2015-12","firstPosted":"2009-06-10","resultsPosted":"2014-10-16","lastUpdate":"2019-09-25"},"enrollment":355,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Gastric Cancer","Adenocarcinoma"],"interventions":[{"type":"BIOLOGICAL","name":"ramucirumab","otherNames":["IMC-1121B","LY3009806"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"OTHER","name":"Best Supportive Care (BSC)","otherNames":[]}],"arms":[{"label":"ramucirumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to gather information about the use of an investigational drug called Ramucirumab in adenocarcinomas of the stomach or gastroesophageal junction.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"Randomization up to 28 months post-randomization","effectByArm":[{"arm":"IMC-1121B (Ramucirumab)","deltaMin":5.2,"sd":null},{"arm":"Placebo","deltaMin":3.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0473"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":18,"exclusionCount":18},"locations":{"siteCount":161,"countries":["United States","Argentina","Australia","Bosnia and Herzegovina","Brazil","Canada","Chile","Colombia","Croatia","Czechia","Egypt","Guatemala","India","Indonesia","Italy","Lebanon","Malta","Mexico","New Zealand","Philippines","Poland","Romania","Russia","South Africa","South Korea","Spain","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["30557792","28716815","24094768"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":112,"n":236},"commonTop":["Fatigue","Decreased appetite","Nausea","Vomiting","Abdominal pain"]}}